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Abstract Ferrochelatase catalyzes the insertion of Fe2?
into protoporphyrin IX. The enzymatic product heme
(protoheme IX) is a well-known cofactor in a wide range of
proteins. The insertion of metal ions other than Fe2? occurs
rarely in vivo, but all ferrochelatases that have been studied
can insert Zn2? at a good rate in vitro. Co2?, but not Cu2?,
is known to be a good substrate of the mammalian
and Saccharomyces cerevisiae ferrochelatases. In contrast,
Cu2?, but not Co2?, has been found to be a good substrate
of bacterial Bacillus subtilis ferrochelatase. It is not known
how ferrochelatase discriminates between different metal
ion substrates. Structural analysis of B. subtilis ferroche-
latase has shown that Tyr13 is an indirect ligand of Fe2?
and a direct ligand of a copper mesoporphyrin product. A
structure-based comparison revealed that Tyr13 aligns with
a Met residue in the S. cerevisiae and human ferrochela-
tases. Tyr13 was changed to Met in the B. subtilis enzyme
by site-directed mutagenesis. Enzymatic measurements
showed that the modified enzyme inserted Co2? at a higher
rate than the wild-type B. subtilis ferrochelatase, but it had lost
the ability to use Cu2? as a substrate. Thus, the B. subtilis
Tyr13Met ferrochelatase showed the same metal specificity as
that of the ferrochelatases from S. cerevisiae and human.
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Abbreviations
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Introduction
Chelatases are a class of enzymes that catalyze the inser-
tion of divalent metal ions into various tetrapyrroles.
Among these are ferrochelatase (i.e., an iron chelatase) and
the magnesium, cobalt, and nickel chelatases. Ferrochela-
tase catalyzes the final step in the synthesis of heme
(protoheme IX), which is the insertion of Fe2? into pro-
toporphyrin IX [1, 2]. The protein is encoded by hemH and
has been found in most species, since heme is essential for
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a large number of biochemical processes. The factors that
determine the metal specificity of different chelatases
remain largely unknown. In the case of ferrochelatase,
which is the best-studied chelatase, metal specificity has
been addressed in a number of in vitro studies [1, 2]. It was
found that the enzyme is promiscuous in vitro and could
insert Zn2?, Co2?, Cu2?, and Ni2? into protoporphyrin IX
in addition to the physiological substrate Fe2? [1, 2].
Although insertion of divalent metal ions other than Fe2?
occurs only rarely in vivo, the formation of zinc proto-
porphyrin in connection to lead poisoning was observed [3,
4]. Interestingly, metal specificity of the ferrochelatase
reaction appears to differ between enzymes from different
host species. Fe2?, Zn2?, and Co2?, but not Cu2?, are
known to be good substrates of Saccharomyces cerevisiae
and mammalian ferrochelatases [5, 6]. On the other hand,
Co2? has been found to be a poor substrate of the bacterial
Bacillus subtilis ferrochelatase, which instead has the
ability to insert Cu2? into protoporphyrin IX at a significant
rate [7].
An analysis of ferrochelatase amino acid sequences
from different species reveals that there are relatively few
invariant amino acid residues across all species (Fig. 1).
Many of these residues are Gly and Pro residues, which are
typically found in regions between secondary structural
elements and are known to be important for the preserva-
tion of the three-dimensional structure within a protein
family [8–10]. The remaining residues are almost exclu-
sively located in the active-site region, where, as shown by
X-ray crystallographic studies, they interact with the metal
ion substrate, the porphyrin substrate, or both [11–13]. In
the case of B. subtilis ferrochelatase, metal soaking of the
crystals and subsequent structure determination has shown
that the physiological substrate Fe2? is bound in a square-
pyramidal geometry, coordinated to the invariant His183
and Glu264 residues, and via water molecules to Tyr13 and
Fig. 1 Alignment of structurally determined ferrochelatases: Bacillus
subtilis [Protein Data Bank (PDB) code 1DOZ], Bacillus anthracis
(PDB code 2C8J), Saccharomyces cerevisiae (PDB code 1LBQ), and
human (PDB code 2QD4). The amino-terminal targeting sequence
has been removed from the eukaryotic sequences. The alignment was
done using the method of combinatorial extension [44]. The Tyr in
the B. subtilis and B. anthracis ferrochelatases and the corresponding
Met in the yeast and human enzymes have been marked with an
arrow. Arrows are also used to mark the conserved His and Glu
residues (numbers 183 and 264 in the B. subtilis sequence), which are
direct ligands to the metal ion substrate. The B. subtilis ferrochelatase
is 73, 24, and 28% identical to the B. anthracis, S. cerevisiae, and
human ferrochelatases, respectively
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the carbonyl group of Ser222 [11]. In a copper N-meth-
ylmesoporphyrin IX or copper mesoporphyrin IX complex
with B. subtilis ferrochelatase, the copper ion is coordi-
nated directly by Tyr13 and by the porphyrin nitrogen
atoms (Fig. 2a) [14, 15]. Interestingly, Tyr13 is the only
residue involved in Fe2? binding that is not conserved. A
structure-based alignment of ferrochelatase sequences
revealed that at the position of Tyr13 in the B. subtilis
enzyme, Met is present in the corresponding enzymes from
S. cerevisiae [9] and humans [16] (Figs. 1, 2b). To assess
the role of Tyr13 in the metal specificity of ferrochelatase,
we performed site-directed mutagenesis of the B. subtilis
enzyme to change this Tyr residue to a Met residue.
Materials and methods
Expression and purification of ferrochelatase
The wild-type and modified B. subtilis ferrochelatases were
expressed in Escherichia coli BL21(DE3) and purified
from inclusion bodies as described by Hansson et al. [17].
Site-directed mutagenesis
Site-directed mutagenesis was performed according to the
QuikChange method (Stratagene) on plasmid pLUGT7-H,
which contains the B. subtilis hemH gene downstream of an
inducible T7 promoter [18]. The following primers were
used: 50-gcttctcgtgatggcgatgggcacgcctta-30 (BsY13Mup1)
and 50-ccttataaggcgtgcccatcgccatcacga-30 (BsY13MLo2).
The mismatches introduced are underlined. The plasmid
was named pLUGT7-HY13M. The correct DNA sequence
was confirmed by sequencing.
X-ray crystallography
Initial crystals of Tyr13Met-modified ferrochelatase were
found by screening under conditions in which wild-type
crystallization was achieved [18]. The initial crystals were
optimized further using seeding techniques as described
earlier [18]. The crystal was transferred to a drop con-
taining well solution supplemented with 10% PEG 400 as a
cryoprotectant. A nylon loop was used to mount the crystal
and flash-freeze it in a stream of boiled-off nitrogen. Dif-
fraction data were collected at the MAX II synchrotron
radiation facility in Lund, Sweden [19]. Data were indexed
and integrated in space group P212121 with the XDS
package [20]. Pseudo-merohedral twinning was detected
using Detwin in the CCP4 package [21]. The twinning
fraction was estimated to be 15% and did not hamper the
structural determination. The structure was initially refined
using simulated annealing in CNS [22], and at later stages
in Refmac5 [23]. The models were built using the graphics
program Coot [24]. The progress of refinement was fol-
lowed by monitoring decreasing R and Rfree values. The
statistics for data collection and refinement are shown in
Table 1. The structure of the Tyr13Met-modified ferro-
chelatase has the Protein Data Bank (PDB) code 3GOQ.
Soaking of wild-type ferrochelatase crystals was con-
ducted by transferring a crystal to a drop containing 10 ll
of well solution supplemented with 5 mM CoCl2, and
incubating the mixture for 30 min. After soaking, the fer-
rochelatase crystal was transferred to another drop containing
well solution with 10% PEG 400 as a cryoprotectant and
mounted as described earlier. Data were collected and pro-
cessed with the XDS package as described earlier. The twin-
ning fraction was similar to that mentioned earlier, and the
structure was solved using the structure of the wild-type
enzyme for initial phasing. Data collection and refinement
statistics are shown in Table 1. The PDB code for the structure
is 3M4Z.
Enzymatic activity measurements
Two 40-ml portions were taken from a master mix con-
sisting of 100 mM tris(hydroxymethyl)aminomethane–
HCl, pH 7.4, 0.3 mg/ml Tween 80, and 1 lM protopor-
phyrin IX (Sigma). Wild-type or Tyr13Met-modified
ferrochelatase was added to one of the portions to a final
concentration of 0.05 lM. The other 40 ml was used for
the negative controls without any enzyme added. A Tecan
Fig. 2 a Copper N-methylmesoporphyrin bound in the active site of
wild-type B. subtilis ferrochelatase, showing Tyr13 as the axial ligand
of the metal ion (PDB code 1C9E). b Structural alignment of B.
subtilis (green) and human (gray) ferrochelatases, showing Tyr13 and
Met76 overlapping in an alignment with an overall root mean square
deviation [25] of 2.0 A˚ (PDB codes 1DOZ and 2QD4)
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robot system (Tecan Group, Switzerland) was used to
transfer 2-ml portions of the mixtures, either containing or
not containing ferrochelatase, into a deep 96-well plate.
The activity with Cu2?, Co2?, and Zn2? was analyzed.
Twenty microliters of CuCl2, CoCl2, or zinc acetate solu-
tions was added to the 2-ml portions, resulting in metal ion
concentrations of between 0.25 and 200 lM. The 2-ml
portions were aliquoted in 300-ll portions in black 96-well
plates. Every second column contained the negative control
samples without any ferrochelatase. For each metal ion
concentration, six replicates were assayed. Since only
zinc protoporphyrin IX is fluorescent, and not cobalt
protoporphyrin IX and copper protoporphyrin IX, the
enzymatic activities were followed from the reduction in
protoporphyrin IX substrate. One unit of protoporphyrin IX
consumed per minute and milligram of protein was regar-
ded as equivalent to the formation of one unit of the cor-
responding metal ion protoporphyrin IX per minute and
milligram of protein. Every 30 min over a 6-h period, the
black 96-well plates were moved to a Magellan M200 plate
reader (Tecan Group, Switzerland) connected to the robot
system. The decrease in protoporphyrin IX was monitored
using an excitation wavelength of 511 nm (slit 9 nm) and
an emission wavelength of 637 nm (slit 20 nm). All
operations were performed in the dark owing to the light
sensitivity of protoporphyrin IX. Assays without added
enzymes were used as controls and the spontaneous
incorporation of metal ion into protoporphyrin IX was
subtracted. The first time points at 0 min were omitted
from the evaluations to avoid pre-steady-state conditions.
EPR spectroscopy
EPR spectra were measured at X-band (approximately
9.5 GHz) using a Bruker ELEXSYS E500 spectrometer fitted
with an Oxford Instruments ESR900 cryostat to allow mea-
surements to be made at cryogenic temperatures using liquid
helium vapor. Temperature control was achieved using an
Oxford Instruments ITC503 temperature controller. The
experimental parameters were as follows: microwave power
0.5 mW, modulation amplitude 5 G, and temperature 15 K.
Results
Metal-specific activity of wild-type
and Tyr13Met-modified ferrochelatase
Site-directed mutagenesis was performed on hemH to change
Tyr13 to Met in the resulting protein. The plasmid carrying
the mutated hemH was named pLUGT7-HY13M. The entire
gene was sequenced from both strands to verify the mutation
and to verify that the remainder of the gene was intact. The
wild-type and Tyr13Met-modified ferrochelatases were pro-
duced in E. coli BL21(DE3) and purified from inclusion
bodies as described earlier [17]. Tyr13Met-modified ferro-
chelatase was crystallized with the microseeding technique
used for the wild-type ferrochelatase [18]. Diffraction data to
a resolution of 1.6 A˚ were collected (Table 1). The final
coordinates were deposited in the PDB (accession code
3GOQ). Although the Met residue replaced the Tyr residue in
the active site, the overall structure was found to be very
similar to that of wild-type B. subtilis ferrochelatase, with a
root mean square deviation [25] between the Ca atoms of
0.2 A˚ (Fig. 3).
Table 1 Statistics for the collected data and quality parameters for
the refined structure of the modified Tyr13Met B. subtilis ferroche-
latase and the wild-type (WT) ferrochelatase soaked in Co2?
Tyr13Met WT soaked
in Co2?
Data collection
Beamline MAX II I911-5 MAX II I911-2
Wavelength (A˚) 0.97935 1.03938
Space group P212121 P212121
Cell dimensions
a, b, c (A˚) 48.33, 49.90,
118.05
48.41, 49.90,
118.08
a, b, c () 90, 90, 90 90, 90, 90
Resolution (A˚) 25.0–1.60
(1.69–1.60)
30–1.94
(1.99–1.94)
Rmerge
a 0.11 (0.42) 0.10 (0.51)
hI/rIi 13.0 (4.5) 22.7 (6.2)
Completeness (%) 97.7 (93.7) 99.9 (100)
Redundancy 7.1 (7.3) 13.5 (13.5)
Refinement
Resolution (A˚) 24.2–1.60
(1.64–1.60)
20–1.94
(1.99–1.94)
No. of reflections 35,770 (2,388) 20,726 (1,484)
Rcryst
b/Rfree
c 0.1978 (0.2325) 0.1684 (0.1985)
RMSDd
Bond lengths (A˚) 0.012 0.012
Bond angles () 1.374 1.248
Ramachandran outlierse 0 0
Ramachandran favored (%)e 97.4 97.7
Values in parentheses are for the highest-resolution shell
RMSD root mean square deviation
a Rmerge =
P
|Ii - hIi|/
P
I, where Ii is an individual intensity mea-
surement and hIi is the average intensity for this reflection
b Rcryst =
P
|Fobs - Fcalc|/
P
Fobs, where Fobs and Fcalc are the
observed and calculated structure factor amplitudes, respectively
c Rfree is the same as Rcryst but calculated on 5% of the data excluded
from refinement
d RMSDs of the parameters from their ideal values
e According to Molprobity structure validation [43]
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Activity measurements showed that wild-type B. subtilis
ferrochelatase inserts Cu2? into protoporphyrin IX at a rate
of 110 pmol/(min mg ferrochelatase) with a KM of 63 lM
(Figs. 4, S1). The activity with Zn2? was 10 times higher:
1,100 pmol/(min mg ferrochelatase), with a KM of 13 lM.
This activity is in good agreement with the activity
reported earlier for the B. subtilis ferrochelatase with Zn2?
[26]. With the modified enzyme with Met at position 13, no
formation of copper protoporphyrin IX or zinc protopor-
phyrin IX could be detected, i.e., the activity of the enzyme
was less than 4.2 pmol/(min mg ferrochelatase). In con-
trast, cobalt protoporphyrin IX was formed at a rate of
57 pmol/(min mg ferrochelatase), which is higher than the
activity of the wild-type enzyme with the same metal as the
substrate [27 pmol/(min mg ferrochelatase)]. A change of
Tyr13 to Met is, however, a severe modification of B.
subtilis ferrochelatase and the KM of 560 lM is consider-
ably higher than the KM of the wild-type enzyme (5.2 lM)
with Co2? as substrate. Clearly, the Tyr13Met modification
of B. subtilis ferrochelatase changes the metal specificity of
the enzyme and results in preference for Co2? over Cu2? as
the substrate. These results are in line with the metal
specificity of the ferrochelatases from S. cerevisiae and
mammals, which naturally have a Met residue in the active
site at the position of Tyr13 in the B. subtilis enzyme.
Fig. 3 Structural alignment of wild-type B. subtilis ferrochelatase
with bound Fe2? (black sphere) (PDB code 2HK6, green) and the
Tyr13Met-modified enzyme (PDB code 3GOQ, magenta). His183
and Glu264 are the only direct ligands of the iron. The only notable
movement is that of Glu264, which is due to the binding of Fe2?. The
overall root mean square deviation is 0.2 A˚. It should be noted that
structures of B. subtilis ferrochelatase in complex with Fe2? (2HK6),
Zn2? (1LD3), and Co2? (3M4Z) are all very similar and have the
metal ions positioned at the same site
Fig. 4 Lineweaver–Burk plots of wild-type and Tyr13Met-modified
B. subtilis ferrochelatase with Cu2? or Co2? as the substrate. The
modified ferrochelatase could insert Co2? into protoporphyrin IX at a
higher rate than the wild-type enzyme, but had lost the ability to insert
Cu2? and Zn2?. V and Vmax are expressed as picomoles of Cu
2?
protoporphyrin IX/Co2? protoporphyrin IX formed per minute and
milligram of protein
J Biol Inorg Chem (2011) 16:235–242 239
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Metal ion binding
The environment of the Cu2? and Co2? ions in the wild-
type and Tyr13Met-modified ferrochelatases was studied
using low-temperature X-band EPR spectroscopy. Cu2?
and Co2? EPR spectra are sensitive reporters concerning
the environment of the ion because the spin and orbital
energies of the ion’s unpaired electrons are affected by the
arrangement and nature of the atoms ligating the ion. EPR
spectroscopy has previously been used in metal-binding
studies of Met8p from S. cerevisiae, a bifunctional dehy-
drogenase and ferrochelatase [27]. The Co2? EPR spectra
show one broad line at around g = 4, typical of mononu-
clear high spin; S = 3/2 for Co2? axial systems with
octahedral symmetry [28]. The high-spin state suggests that
there are mainly, but not exclusively, oxygen ligands rather
than nitrogen ligands in the immediate environment of the
metal ion. For Co2? in buffer without ferrochelatase, the
spectrum appears at g\ = 4.4 with a half-height linewidth
of 520 G (Fig. 5). In the presence of wild-type or Tyr13-
Met-modified ferrochelatase, the spectrum shifts to
g\ = 4.3 with a half-height linewidth of 600 G. There is
also evidence of a weak g|| feature at g * 3 in all spectra,
and further lines around g = 2.0–2.3 arise from contami-
nating Cu2? in the EPR resonator. The Cu2? EPR spectra
are consistent with an S =  ground state bearing the
unpaired electron in the dx2y2 orbital with distorted octa-
hedral symmetry. For Cu2? in buffer without enzyme, the
axial spectrum has g\ = 2.05 with g|| = 2.25 and
A|| = 175 G, whereas in the presence of wild-type or
Tyr13Met-modified ferrochelatase we observed g\ = 2.06
with g|| = 2.27 and A|| = 170 G. A minor species with
g|| = 2.22 and A|| = 166 G constituted about 10% of the
observed Cu2? signal. These spectra are consistent with a
metal ion environment that is dominated by oxygen ligation,
with one possible nitrogen ligand [29]. Overall, the EPR
analysis demonstrates that the two metal ions are bound in
identical fashion in the wild-type and the Tyr13Met enzymes
(Fig. 5).
The mode of metal binding suggested by the EPR
experiments was further confirmed by an X-ray crystallo-
graphic study of binding of Co2? to ferrochelatase. Crystals
of wild-type ferrochelatase were soaked in 5 mM CoCl2 for
30 min. Difference electron density maps clearly demon-
strated the presence of Co2? at the active site of the
enzyme (up to 10r, Fig. 6). The metal was coordinated by
the invariant amino acid residues His183 and Glu264, and
by four water molecules in a distorted octahedral fashion.
Tyr13 appears to stabilize one of the water molecules in the
second coordination sphere of the metal. The position of
the Co2? ion in the structure is very similar to the binding
positions seen earlier in both B. subtilis and S. cerevisiae
ferrochelatase [9, 11, 26]. Moreover, three of the four water
molecules in the Co2? coordination sphere can be super-
imposed on all three water molecules in the Fe2? coordi-
nation sphere. In addition, in the Co2?-soaked structure,
Mg2?—which is essential for crystal formation and which
has been observed in most B. subtilis crystal structures—
remained 7.7 A˚ from the Co2? ion (7.8 A˚ from Fe2?). It is
Fig. 5 X-band EPR spectra of ferrochelatases and metal ion controls
(1 equiv is equal to the protein concentration): a 1 equiv of Co2? ions
in buffer; b 1 equiv of Co2? ions with wild-type ferrochelatase; c 1
equiv of Co2? ions with Tyr13Met-modified ferrochelatase; d 1 equiv
of Cu2? ions in buffer; e 1 equiv of Cu2? ions with wild-type
ferrochelatase; f 1 equiv of Cu2? ions with Tyr13Met-modified
ferrochelatase. Each spectrum was the co-added sum of three scans.
The experimental parameters were as follows: microwave power
0.5 mW, modulation amplitude 5 G, temperature 15 K
240 J Biol Inorg Chem (2011) 16:235–242
123
interesting to note that Mg2? is absent from the Zn2?-
soaked structure, which has been suggested to be an effect
of repulsive interactions between the two metal ions [17].
Discussion
To assess the specificity of the metallation reaction cata-
lyzed by ferrochelatase, we changed Tyr to Met at position
13 of the B. subtilis ferrochelatase using site-directed
mutagenesis. The modified Tyr13Met enzyme could insert
Co2? into protoporphyrin IX at a higher rate than the wild-
type enzyme, but no activity with Cu2? and Zn2? could be
detected. Our experiments clearly demonstrate that the
Tyr13Met substitution does indeed affect the metal speci-
ficity of the ferrochelatase reaction, although both EPR
data and the X-ray crystallographic model of the Co2?-
soaked enzyme showed that both Cu2? and Co2? bind to B.
subtilis ferrochelatase in a manner that is insensitive to the
Tyr13Met substitution. Furthermore, we found that Co2?
binds to the same amino acid residues in the ferrochelatase
structure as those used for Fe2? and Zn2? [11, 26]. These
observations suggest that metal substrate specificity is not
determined at the stage of binding of the metal ion to the
enzyme, but rather at a later stage of the reaction. Are there
any previous observations to support this suggestion?
Distortion of the porphyrin ring is strongly believed to be
a key feature of the ferrochelatase reaction mechanism
[30–33]. Distorted porphyrins are also seen in X-ray
crystallographic structures of ferrochelatase in complex
with porphyrin [12, 14, 16]. The distortion is believed to
serve the enzymatic reaction by exposing the nitrogen
atoms of the porphyrin to the incoming metal ion. Recent
kinetic studies on human ferrochelatase have demonstrated
that product release in vitro is at least 10 times slower than
metal insertion, which led to the conclusion that release of
the product is the overall rate-limiting step in the reaction
[34]. Theoretical simulations have shown that the energy
required to distort a metallated porphyrin is normally
higher than the energy required to distort an empty por-
phyrin. This means that the release of a metallated product
is energetically favorable, and it suggests that the release
mechanism may explore the differences in energy between
a distorted metal-containing porphyrin and a metal-free
porphyrin [32]. One exception is cadmium porphyrin,
which requires less energy to be tilted than the neutral
metal-free ring [32]. In accordance with theoretical calcu-
lations, it was found that Cd could be inserted into por-
phyrin by human ferrochelatase in vitro, but the product of
the reaction, cadmium porphyrin, was retained by the
enzyme [35]. These observations also support the idea that
inhibition of the ferrochelatase reaction by metallopor-
phyrin may contribute to control of the metal substrate
specificity of the enzyme. Combined, the present and pre-
vious studies suggest that ferrochelatase does not have the
ability to discriminate between transition metal ion sub-
strates in the binding phase of the reaction. Still, the overall
ferrochelatase reaction shows metal specificity. We regard
this metal specificity as apparent because it is related to the
release of the product after the metal insertion into the
porphyrin has been completed. How could a change of
Tyr13 to Met in the B. subtilis ferrochelatase affect this
apparent metal specificity of Cu2? versus Co2?? Our pre-
vious work has demonstrated that a His183Ala replacement
in the active site of B. subtilis ferrochelatase affects the
mode of porphyrin distortion, suggesting that the binding
site of the enzyme is optimized for enforcing a certain type
of distortion on the bound porphyrin [12]. It would be
logical to assume that the binding site is also optimized for
release of a certain metallated product. Our previous
analysis has shown that Tyr13 is involved in binding of the
metal ion substrate, but only as an indirect ligand mediated
via water [26]. In contrast, Tyr13 is a direct ligand to the
metal ion in copper N-methylmesoporphyrin IX and copper
mesoporphyrin IX complexes [14, 15]. It can therefore be
speculated that a Tyr or Met residue in the active site may
influence the binding of a metalloporphyrin to a greater
extent than it can influence the binding of the plain metal
ion. It should be noted that Co2? is a harder ion than Cu2?
[36]. Thus, cobalt protoporphyrin should have a stronger
affinity for hard ligands, such as the oxygen of the hydroxyl
Fig. 6 Cobalt bound in the active site of B. subtilis ferrochelatase
(PDB code 3M4Z). Co2? is coordinated to His183, Glu264, and four
water molecules. Tyr13 is an indirect ligand of Co2? via water
J Biol Inorg Chem (2011) 16:235–242 241
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group of Tyr13, providing an axial ligand to the metallo-
porphyrin. Thus, the cobalt protoporphyrin product should
be retained by Tyr13 in the B. subtilis ferrochelatase.
Correspondingly, the softer copper in copper protopor-
phyrin should be retained more strongly by the softer sulfur
of Met, negatively affecting the release of product from the
Tyr13Met enzyme as well as from the S. cerevisiae and
mammalian ferrochelatases.
Our study indicates that ferrochelatase does not have a
built-in mechanism to discriminate between incoming
transition metal ion substrates. Instead, an in vivo metal
delivery system is likely to exist, one that is metal-specific
and ensures the delivery of Fe2? to ferrochelatase. Frataxin
and mitoferrin have been suggested to function as Fe2?
chaperones of the ferrochelatase reaction [37–40]. No
homologs can be found when prokaryotic genomes are
screened in bioinformatic searches. Thus, it is uncertain
whether they are Fe2? chaperones that are universal for
ferrochelatases of all species. Recently, however, Qi and
Cowan [41] reported that the B. subtilis protein YdhG is
structurally and functionally similar to frataxin, even though
there was no sequence homology. The conserved residue
Ser54 in the B. subtilis ferrochelatase has been suggested to
be part of a docking site for a protein with the function of
delivering any of the two substrates, or retrieving the heme
product [42]. A future challenge will be to identify and
understand the trafficking of substrates and product of fer-
rochelatase and the proteins that interact with it.
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